glp-1 approved for pediatrics SCALE KIDS Trial: Evaluating Liraglutide's Role in Pediatric Obesity Management GLP-1 receptor agonists and obesity

Patients often achieve optimal results by pairing their medication with healthy lifestyle changes

The format point matters clinically

However, this legal framework remains contested, and the regulatory landscape continues to evolve

While treatment with GLP-1RAs did not yield a significant change in estimated glomerular filtration rate [SMD 0.07 ml/min/1.73 m 2 (95% CI 0.640.50)] or creatinine [SMD 0.08 mg/dl (95% CI 0.440.28)], they were associated with a significant decrease in urine protein:creatinine ratio [SMD 0.47 (95% CI 0.77 to 0.18)] and haemoglobin A1c levels [MD 0.85% (95% CI 1.41 to 0.28)]

Humans are exposed to MPs through various routes, including environmental air, daily-use products, and personal care items